Filing Details

Accession Number:
0001642545-24-000040
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-07 20:17:11
Reporting Period:
2024-02-05
Accepted Time:
2024-02-07 20:17:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1642545 Shockwave Medical Inc. SWAV Surgical & Medical Instruments & Apparatus (3841) 270494101
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1911088 Trinh Phung C/O Shockwave Medical, Inc.
5403 Betsy Ross Drive
Santa Clara CA 95054
Vp, Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-02-05 942 $226.28 34,806 No 4 F Direct
Common Stock Disposition 2024-02-05 505 $226.29 34,301 No 4 F Direct
Common Stock Disposition 2024-02-05 81 $226.27 34,220 No 4 F Direct
Common Stock Disposition 2024-02-06 267 $230.89 33,953 No 4 S Direct
Common Stock Disposition 2024-02-06 748 $232.36 33,205 No 4 S Direct
Common Stock Disposition 2024-02-06 272 $232.97 32,933 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 F Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 09/07/23.
  2. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $230.51 to $231.41. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  3. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $231.76 to $232.72. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  4. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $232.76 to $233.00. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.